tradingkey.logo

India's top drugmaker Sun Pharma's Q3 profit beats estimates on strong local sales

ReutersJan 31, 2025 9:45 AM

- Sun Pharmaceutical SUN.NS, India's largest drugmaker by revenue, reported a bigger-than-expected quarterly profit on Friday, aided by strong sales in the domestic market.

The Mumbai-based firm's consolidated net profit rose 15% to 29.03 billion rupees ($335.3 million) in third quarter, beating analysts' average estimate of 28.81 billion rupees, according to data compiled by LSEG.

($1 = 86.5860 Indian rupees)

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI